O
8.14
0.46 (5.99%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Oruka Therapeutics, Inc. | Bearish | - |
AIStockmoo Score
0.4
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.38 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.26% |
| % Held by Institutions | 85.77% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 45.00 (HC Wainwright & Co., 452.83%) | Buy |
| Median | 32.50 (299.26%) | |
| Low | 20.00 (Wolfe Research, 145.70%) | Buy |
| Average | 32.50 (299.26%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 12.81 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Feb 2025 | 45.00 (452.83%) | Buy | 11.40 |
| Wolfe Research | 04 Feb 2025 | 20.00 (145.70%) | Buy | 14.21 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Mar 2025 | Announcement | Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting |
| 06 Mar 2025 | Announcement | Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update |
| 19 Feb 2025 | Announcement | Oruka Therapeutics to Present at Multiple March Investor Conferences |
| TTM Dividend Yield | 19.82% |
| 1Y Average Dividend Yield | 8.32% |
| Expected Next Dividend Payment | Aug 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |